The store will not work correctly when cookies are disabled.
3-(5-((4-Chlorobenzyl)sulfanyl)-1,3,4-oxadiazol-2-yl)-5-nitroaniline
ID: ALA4101143
PubChem CID: 137660526
Max Phase: Preclinical
Molecular Formula: C15H11ClN4O3S
Molecular Weight: 362.80
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cc(-c2nnc(SCc3ccc(Cl)cc3)o2)cc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C15H11ClN4O3S/c16-11-3-1-9(2-4-11)8-24-15-19-18-14(23-15)10-5-12(17)7-13(6-10)20(21)22/h1-7H,8,17H2
Standard InChI Key: INDMVRPYSWGEPM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
2.5850 -4.2235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2018 -4.7595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9745 -4.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1302 -3.6911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5134 -3.1551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7408 -3.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9180 -3.4079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5888 -3.8745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2400 -3.3808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9738 -2.6081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1582 -2.6081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0218 -3.6184 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.6185 -3.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4005 -3.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5856 -4.0936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3675 -4.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9642 -3.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7791 -2.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9972 -2.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7461 -4.0105 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.0461 -5.5617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1211 -2.8858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3485 -3.1521 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2769 -2.0836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
2 21 1 0
22 23 2 0
22 24 1 0
6 22 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.80 | Molecular Weight (Monoisotopic): 362.0240 | AlogP: 4.17 | #Rotatable Bonds: 5 |
Polar Surface Area: 108.08 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.53 | CX LogP: 3.63 | CX LogD: 3.63 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.31 | Np Likeness Score: -2.16 |
References
1. Karabanovich G, Němeček J, Valášková L, Carazo A, Konečná K, Stolaříková J, Hrabálek A, Pavliš O, Pávek P, Vávrová K, Roh J, Klimešová V.. (2017) S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents., 126 [PMID:27907875] [10.1016/j.ejmech.2016.11.041] |